Magnetic resonance imaging radiomics-based prediction of clinically significant prostate cancer in equivocal PI-RADS 3 lesions in the transitional zone

被引:5
|
作者
Zhao, Ying-Ying [1 ]
Xiong, Mei-Lian [2 ]
Liu, Yue-Feng [3 ]
Duan, Li-Juan [1 ]
Chen, Jia-Li [1 ]
Xing, Zhen [2 ]
Lin, Yan-Shun [1 ]
Chen, Tan-Hui [2 ]
机构
[1] Fujian Med Univ, Fuqing City Hosp, Dept Radiol, Fuqing, Peoples R China
[2] Fujian Med Univ, Dept Nephrol, Affiliated Hosp 1, Fuzhou, Fujian, Peoples R China
[3] Hubei Univ Med, Taihe Hosp, Dept Ophthalmol, Shiyan, Hubei, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词
magnetic resonance imaging; prostate cancer; PI-RADS; transitional zone; radiomics; MR; CLASSIFICATION; ASSOCIATION; STATISTICS; BIOPSY; SCORE; RISK;
D O I
10.3389/fonc.2023.1247682
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: This bi-institutional study aimed to establish a robust model for predicting clinically significant prostate cancer (csPCa) (pathological grade group >= 2) in PI-RADS 3 lesions in the transition zone by comparing the performance of combination models.Materials and methods: This study included 243 consecutive men who underwent 3-Tesla magnetic resonance imaging (MRI) and ultrasound-guided transrectal biopsy from January 2020 and April 2022 which is divided into a training cohort of 170 patients and a separate testing cohort of 73 patients. T2WI and DWI images were manually segmented for PI-RADS 3 lesions for the mean ADC and radiomic analysis. Predictive clinical factors were identified using both univariate and multivariate logistic models. The least absolute shrinkage and selection operator (LASSO) regression models were deployed for feature selection and for constructing radiomic signatures. We developed nine models utilizing clinical factors, radiological features, and radiomics, leveraging logistic and XGboost methods. The performances of these models was subsequently compared using Receiver Operating Characteristic (ROC) analysis and the Delong test.Results: Out of the 243 participants with a median age of 70 years, 30 were diagnosed with csPCa, leaving 213 without a csPCa diagnosis. Prostate-specific antigen density (PSAD) stood out as the only significant clinical factor (odds ratio [OR], 1.068; 95% confidence interval [CI], 1.029-1.115), discovered through the univariate and multivariate logistic models. Seven radiomic features correlated with csPCa prediction. Notably, the XGboost model outperformed eight other models (AUC of the training cohort: 0.949, and validation cohort: 0.913). However, it did not surpass the PSAD+MADC model (P > 0.05) in the training and testing cohorts (AUC, 0.949 vs. 0.888 and 0.913 vs. 0.854, respectively).Conclusion: The machine learning XGboost model presented the best performance in predicting csPCa in PI-RADS 3 lesions within the transitional zone. However, the addition of radiomic classifiers did not display any significant enhancement over the compound model of clinical and radiological findings. The most exemplary and generalized option for quantitative prostate evaluation was Mean ADC+PSAD.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Magnetic Resonance Imaging Radiomics-Based Machine Learning Prediction of Clinically Significant Prostate Cancer in Equivocal PI-RADS 3 Lesions
    Hectors, Stefanie J.
    Chen, Christine
    Chen, Johnson
    Wang, Jade
    Gordon, Sharon
    Yu, Miko
    Al Hussein Al Awamlh, Bashir
    Sabuncu, Mert R.
    Margolis, Daniel J. A.
    Hu, Jim C.
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2021, 54 (05) : 1466 - 1473
  • [2] Editorial for "MRI Radiomics-Based Machine Learning for Predict of Clinically Significant Prostate Cancer in Equivocal PI-RADS 3 Lesions"
    Nketiah, Gabriel A.
    Bathen, Tone F.
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2021, 54 (05) : 1474 - 1475
  • [3] Biparametric MRI-based radiomics for prediction of clinically significant prostate cancer of PI-RADS category 3 lesions
    Lu, Feng
    Zhao, Yanjun
    Wang, Zhongjuan
    Feng, Ninghan
    BMC CANCER, 2025, 25 (01)
  • [4] Development and Validation of a Radiomics Nomogram for Predicting Clinically Significant Prostate Cancer in PI-RADS 3 Lesions
    Li, Tianping
    Sun, Linna
    Li, Qinghe
    Luo, Xunrong
    Luo, Mingfang
    Xie, Haizhu
    Wang, Peiyuan
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [5] A radiomics machine learning-based redefining score robustly identifies clinically significant prostate cancer in equivocal PI-RADS score 3 lesions
    Hou, Ying
    Bao, Mei-Ling
    Wu, Chen-Jiang
    Zhang, Jing
    Zhang, Yu-Dong
    Shi, Hai-Bin
    ABDOMINAL RADIOLOGY, 2020, 45 (12) : 4223 - 4234
  • [6] A radiomics machine learning-based redefining score robustly identifies clinically significant prostate cancer in equivocal PI-RADS score 3 lesions
    Ying Hou
    Mei-Ling Bao
    Chen-Jiang Wu
    Jing Zhang
    Yu-Dong Zhang
    Hai-Bin Shi
    Abdominal Radiology, 2020, 45 : 4223 - 4234
  • [7] Post Prostatectomy Pathologic Findings of Patients With Clinically Significant Prostate Cancer and no Significant PI-RADS Lesions on Preoperative Magnetic Resonance Imaging
    Alanee, Shaheen
    Deebajah, Mustafa
    Taneja, Kanika
    Cole, Daniel
    Pantelic, Milan
    Peabody, James
    Williamson, Sean R.
    Gupta, Nilesh
    Dabaja, Ali
    Menon, Mani
    UROLOGY, 2020, 146 : 183 - 187
  • [8] Transverse prostate maximum sectional area can predict clinically significant prostate cancer in PI-RADS 3 lesions at multiparametric magnetic resonance imaging
    Gaudiano, Caterina
    Braccischi, Lorenzo
    Taninokuchi Tomassoni, Makoto
    Paccapelo, Alexandro
    Bianchi, Lorenzo
    Corcioni, Beniamino
    Ciccarese, Federica
    Schiavina, Riccardo
    Droghetti, Matteo
    Giunchi, Francesca
    Fiorentino, Michelangelo
    Brunocilla, Eugenio
    Golfieri, Rita
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [9] Post Prostatectomy Pathologic Findings of Patients With Clinically Significant Prostate Cancer and no Significant PI-RADS Lesions on Preoperative Magnetic Resonance Imaging COMMENT
    Walker, Colton
    Singhal, Udit
    Tosoian, Jeffrey J.
    UROLOGY, 2020, 146 : 187 - 188
  • [10] Post Prostatectomy Pathologic Findings of Patients With Clinically Significant Prostate Cancer and no Significant PI-RADS Lesions on Preoperative Magnetic Resonance Imaging REPLY
    Alanee, Shaheen
    Peabody, James
    Menon, Mani
    UROLOGY, 2020, 146 : 188 - 188